Biovie Inc Stock Performance
| BIVI Stock | USD 3.06 0.04 1.29% |
Biovie holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.0413, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biovie's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biovie is expected to be smaller as well. Use Biovie semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Biovie.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biovie Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Biovie demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.29) | Five Day Return 13.33 | Year To Date Return (77.66) | Ten Year Return (90.21) | All Time Return (99.18) |
Last Split Factor 1:10 | Dividend Date 2019-11-22 | Last Split Date 2024-08-06 |
1 | BioVie Secures All Scientific Approvals Needed to Receive Additional 12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Lon... | 09/16/2024 |
2 | BioVie plummets 50, prices 3M gross proceeds | 09/24/2024 |
3 | BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement | 10/22/2024 |
4 | Join BioVies Exclusive Live Investor Webinar and QA Session on November 7th, 2024 | 10/23/2024 |
5 | BioVie Inc. Announces Closing of Registered Direct Offering BIVI Stock News - StockTitan | 10/29/2024 |
6 | Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3 | 11/07/2024 |
7 | BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID ... | 11/20/2024 |
| Begin Period Cash Flow | 19.5 M |
Biovie |
Biovie Relative Risk vs. Return Landscape
If you would invest 263.00 in Biovie Inc on September 5, 2024 and sell it today you would earn a total of 43.00 from holding Biovie Inc or generate 16.35% return on investment over 90 days. Biovie Inc is currently generating 1.4822% in daily expected returns and assumes 17.0929% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Biovie, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biovie Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biovie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biovie Inc, and traders can use it to determine the average amount a Biovie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0867
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BIVI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.09 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.48 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Biovie is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biovie by adding it to a well-diversified portfolio.
Biovie Fundamentals Growth
Biovie Stock prices reflect investors' perceptions of the future prospects and financial health of Biovie, and Biovie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biovie Stock performance.
| Return On Equity | -2.08 | ||||
| Return On Asset | -0.67 | ||||
| Current Valuation | 38.77 M | ||||
| Shares Outstanding | 17.77 M | ||||
| Price To Earning | 18.12 X | ||||
| Price To Book | 3.92 X | ||||
| EBITDA | (31.95 M) | ||||
| Net Income | (32.12 M) | ||||
| Cash And Equivalents | 18.64 M | ||||
| Cash Per Share | 0.62 X | ||||
| Total Debt | 6.11 M | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.50 X | ||||
| Book Value Per Share | 2.50 X | ||||
| Cash Flow From Operations | (27.95 M) | ||||
| Earnings Per Share | (5.08) X | ||||
| Market Capitalization | 55.08 M | ||||
| Total Asset | 25.21 M | ||||
| Retained Earnings | (334.23 M) | ||||
| Working Capital | 19.55 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 961 K | ||||
About Biovie Performance
By evaluating Biovie's fundamental ratios, stakeholders can gain valuable insights into Biovie's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biovie has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biovie has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.31) | (1.38) | |
| Return On Capital Employed | (2.03) | (2.13) | |
| Return On Assets | (1.27) | (1.34) | |
| Return On Equity | (2.07) | (2.18) |
Things to note about Biovie Inc performance evaluation
Checking the ongoing alerts about Biovie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biovie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biovie Inc is way too risky over 90 days horizon | |
| Biovie Inc appears to be risky and price may revert if volatility continues | |
| Biovie Inc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (32.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovie Inc currently holds about 18.64 M in cash with (27.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62. | |
| Biovie Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID ... |
- Analyzing Biovie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biovie's stock is overvalued or undervalued compared to its peers.
- Examining Biovie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biovie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biovie's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biovie's stock. These opinions can provide insight into Biovie's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |